Euglena Co., Ltd. (2931) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Euglena Co., Ltd. (2931:JPX), powered by AI.

Current Price
¥338
P/E Ratio
-57.3
Market Cap
46.1B
Sector
Consumer Defensive
What is the Euglena Co., Ltd. stock price forecast?

Euglena Co., Ltd. is currently trading at ¥338. View real-time AI analysis on Alpha Lenz.

What is Euglena Co., Ltd. insider trading activity?

View the latest insider trading data for Euglena Co., Ltd. on Alpha Lenz.

What is Euglena Co., Ltd.'s P/E ratio?

Euglena Co., Ltd.'s P/E ratio is -57.3.

Euglena Co., Ltd.

JPX · 2931
¥338-2(-0.59%)Market closedJPX regular session 09:00–15:00 JST
Ask about Euglena Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Euglena Co., Ltd. trades at a P/E of -57.3 (undervalued) with modest ROE of -2.6%.

Ask for details

Company Overview

Euglena Co., Ltd. is a biotechnology company that primarily focuses on the research, development, and commercialization of products derived from euglena, a type of microalgae. This asset is integral in the biofuels, nutrition, and cosmetics industries, leveraging the high nutritional value and diverse applications of euglena. The company's offerings include health foods and supplements, as well as environmentally friendly biofuels, showcasing its commitment to sustainability and innovative solutions. Established with a forward-thinking approach, Euglena Co., Ltd. plays a significant role in promoting alternative energy sources and contributing to health and wellness markets. By harnessing the unique properties of euglena, the company not only supports the growing demand for sustainable products but also advances efforts in reducing the carbon footprint associated with traditional energy and consumer products. With its headquarters in Tokyo, Japan, Euglena Co., Ltd. continues to expand its impact across various sectors, enhancing its market presence and contributing to environmental and health-focused initiatives worldwide.

CEOMr. Tomohiro Wakahara
SectorConsumer Defensive
IndustryHousehold & Personal Products
Employees897

Company Statistics

FY 2025

Profile

¥46,116,949,164Market Cap
¥50,370,000,000Revenue
0.00Shares Out
897Employees

Margins

69.55%Gross
12.26%EBITDA
6.20%Operating
3.75%Pre-Tax
1.04%Net

Valuation

-57.29P/E
1.49P/B
0.92EV/Sales
8.13EV/EBITDA
10.04P/FCF

Growth (CAGR)

4.30%Rev 3Yr
30.48%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

0.72%ROA
-2.57%ROE
3.23%ROIC

Financial Health

¥21,163,000,000Cash & Cash Equivalents
¥22,642,000,000Net Debt
153.56%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Euglena Co., Ltd. (ticker: 2931) is a company listed on JPX in the Consumer Defensive sector (Household & Personal Products). It has approximately 897 employees. Market cap is $46.1B.

The current price is 338 with a P/E ratio of -57.29x and P/B of 1.49x.

ROE is -2.57% and operating margin is 6.20%. Annual revenue is $50.4B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Euglena Co., Ltd. (2931) Stock Forecast 2026 ¥338 — Price, Financials & Analyst Targets | Alpha Lenz